Notice of Application to Register a Trade Name Product (Notice No. MPI ACVM 107)
Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:
Trade Name: Eurican Oral Bordetella
Reference: A012246
Active Ingredients and Concentrations:
Each 1 mL dose contains:
Lyophilisate: Attenuated Bordetella bronchiseptica Minimum 108.5 CFU/1 mL, Maximum 109.8 CFU/1 mL
Formulation Type: Lyophilisate with aqueous diluent
Application method/administration route: Oral
Use Claim:
For vaccination of healthy dogs 8 weeks of age or older as an aid in preventing canine infectious tracheobronchitis (canine cough complex) caused by Bordetella bronchiseptica.
Any person may make a written submission to the Director-General concerning this application. Under sections 16 and 17 of the Act, a written submission:
Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.
The following address is:
ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.
MPI encourages submission by email.
The applicant’s address for service is:
Boehringer Ingelheim Animal Health New Zealand Limited, Level 2, 3 Te Kehu Way, Mount Wellington, Auckland 1060. Postal Address: PO Box 76211, Manukau, Auckland 2241.
Dated at Wellington this 19th day of December 2025.
SHALEEN NARAYAN, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).